company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,87540286.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,946621.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,88486907.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,160596.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1301250.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,898523.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,104892.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2304665.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,,totalassets,Total Assets,=,debit,usd,90952168.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,625000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2133904.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1726767.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,592825.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5078496.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,9375000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,860761.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10235761.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15314257.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,181297236.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-106425961.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-373.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,767009.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,75637911.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,75637911.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,75637911.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q2,,2011-06-30,2011-08-12 16:18:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,90952168.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36089532.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,46827543.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,654249.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,83571324.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,251990.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,829608.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,104892.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,934500.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,,totalassets,Total Assets,=,debit,usd,84757814.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1250002.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1003260.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3276815.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,935662.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6465739.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8749998.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,871259.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9621257.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16086996.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,185261740.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-116546460.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-373.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-44089.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,68670818.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,68670818.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,68670818.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2011.0,Q3,,2011-09-30,2011-11-14 16:57:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,84757814.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,31883550.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,31625565.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,991815.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,64500930.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,629000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,365001.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,104892.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,469893.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,,totalassets,Total Assets,=,debit,usd,65599823.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,277777.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1853416.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4820121.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6951314.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,9722223.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,85999.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9808222.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16759536.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,190953859.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-142122118.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-373.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,8919.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,48840287.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,48840287.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,48840287.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q1,,2012-03-31,2012-05-10 13:58:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,65599823.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,64711246.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,35907306.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,793650.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,101412202.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,652115.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,93915.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,104892.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,198807.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,,totalassets,Total Assets,=,debit,usd,102263124.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1111111.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2233637.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4876589.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8221337.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8888889.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,115713.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9004602.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17225939.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,241101547.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-156049371.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-373.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-14618.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,85037185.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,85037185.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,85037185.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q2,,2012-06-30,2012-08-09 11:30:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,102263124.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44046005.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,51416793.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1379998.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,96842796.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,738148.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,86608.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,104892.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,191500.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,,totalassets,Total Assets,=,debit,usd,97772444.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2102540.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2494504.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6312155.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10909199.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8424443.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,144527.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8568970.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19478169.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,249195250.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-170923364.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-373.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,22762.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,78294275.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,78294275.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,78294275.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2012.0,Q3,,2012-09-30,2012-11-09 14:36:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,97772444.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,66733000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,73956000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,763000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,841000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2233000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,144526000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1236000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,93000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,105000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,198000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,,totalassets,Total Assets,=,debit,usd,145960000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3578000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1496000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7236000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12310000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,6695000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,190000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6885000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19195000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,337660000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-210864000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-31000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,126765000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,126765000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,126765000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q1,,2013-03-31,2013-05-10 14:38:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,145960000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44533000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,84603000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3239000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1441000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1793000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,135609000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1386000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,98000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,105000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,203000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,,totalassets,Total Assets,=,debit,usd,137198000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3578000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1303000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9372000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14253000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5800000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,205000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6005000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,20258000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,346755000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-229761000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-54000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,116940000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,116940000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,116940000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q2,,2013-06-30,2013-08-09 12:43:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,137198000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,49244000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,76924000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4609000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1488000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3186000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,135451000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1486000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,164000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,164000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,,totalassets,Total Assets,=,debit,usd,137101000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3578000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1197000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12261000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17036000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,4906000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,309000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5215000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22251000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,357060000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-242228000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,18000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,114850000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,114850000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,114850000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2013.0,Q3,,2013-09-30,2013-11-08 14:02:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,137101000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,63201000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,53564000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9338000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3917000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4266000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,134286000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2153000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,237000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,237000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,,totalassets,Total Assets,=,debit,usd,136676000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3578000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3951000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17378000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24907000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3117000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1064000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4181000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,29088000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,379464000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-271856000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-20000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,107588000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,107588000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,107588000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q1,,2014-03-31,2014-05-09 14:12:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,136676000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46650000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,58037000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12437000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6836000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7064000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,131024000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3385000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,210000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,210000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,,totalassets,Total Assets,=,debit,usd,134619000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3578000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1950000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18498000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24026000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2222000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1794000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4016000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,28042000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,388161000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-281478000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-106000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,106577000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,106577000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,106577000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q2,,2014-06-30,2014-08-08 13:42:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,134619000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,315153000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,52445000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14225000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10299000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5017000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,397139000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4364000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5533000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5533000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,,totalassets,Total Assets,=,debit,usd,407036000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3517000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4667000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23833000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32017000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,211732000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1778000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,213510000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,245527000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,484067000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-287349000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-209000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,161509000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,161509000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,161509000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2014.0,Q3,,2014-09-30,2014-11-10 15:50:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,407036000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67382000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,20076000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,45076000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9365000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,141899000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4694000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12500000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,266365000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13227000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,292092000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,,totalassets,Total Assets,=,debit,usd,438685000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6943000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,32196000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39139000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,219329000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,27228000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,246557000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,285696000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,499836000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-311290000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-557000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,152989000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,152989000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,152989000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q1,,2015-03-31,2015-05-08 15:07:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,438685000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,82562000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23967000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,58641000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9965000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,175243000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4550000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,9100000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,254613000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6254000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,269967000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,,totalassets,Total Assets,=,debit,usd,449652000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9977000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,37970000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,47947000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,224078000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,27873000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,251951000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,299898000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,507504000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-322440000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-310000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,149754000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,149754000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,149754000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q2,,2015-06-30,2015-08-17 17:09:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,449652000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,71738000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,18221000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,57038000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,12761000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,25505000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,185263000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4674000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,9100000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,249519000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4777000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,263396000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,,totalassets,Total Assets,=,debit,usd,453333000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10675000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,40529000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,25000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,76204000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,228964000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3109000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,232073000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,308277000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,512323000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-332205000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-62000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,145056000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,145056000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,145056000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2015.0,Q3,,2015-09-30,2015-11-09 16:15:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,453333000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42718000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10821000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,54966000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13099000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,25535000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,147139000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4862000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,9600000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,237871000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,952000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,248423000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,,totalassets,Total Assets,=,debit,usd,400424000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9366000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,35724000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,65313000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,110403000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,235117000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1426000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,236543000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,346946000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,523135000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-434358000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-299000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,53478000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,53478000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,53478000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q1,,2016-03-31,2016-05-16 16:13:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,400424000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46064000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9077000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,43889000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13192000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,26141000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,138363000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4465000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,232825000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,225000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,233050000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,,totalassets,Total Assets,=,debit,usd,375878000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2841000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5141000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,48981000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,65383000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,122346000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,240687000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1722000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,242409000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,364755000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,527819000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-481167000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-529000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,11123000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,11123000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11123000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q2,,2016-06-30,2016-08-09 16:01:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,375878000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,32363000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7843000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,41517000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13007000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,26048000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,120778000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4744000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,227779000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,525000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,228304000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,,totalassets,Total Assets,=,debit,usd,353826000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2915000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9953000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,40410000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,65509000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,118787000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,246420000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1445000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,247865000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,366652000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,530563000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-507700000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-35000000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-656000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-12793000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-12826000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-12826000.0
Aegerion Pharmaceuticals Inc,AEGR,549300PFYFSCKFOY5J36,0001338042,2016.0,Q3,,2016-09-30,2016-11-04 17:30:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,353826000.0
